文献速递肝病消化道肿瘤与早癌

内脏肥胖增加男性肝硬化患者肝细胞癌风险及肝移植后复发风险

Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant.
PubMed 文献 · Hepatology · 2018-01-26

研究评估内脏脂肪组织是否与肝硬化患者肝细胞癌风险及肝移植后复发相关。678例肝硬化患者(457例男性,289例伴肝细胞癌)接受身体成分分析,其中247例(168例男性)行肝移植。结果显示,男性肝细胞癌患者内脏脂肪指数较高(75±3 vs 60±3 cm²/m²,P=0.001),内脏脂肪指数≥65 cm²/m²者肝细胞癌风险更高(HR 1.90),肝移植后复发风险亦更高(HR 5.34)。

要点

  • 男性肝硬化患者中,肝细胞癌组内脏脂肪指数高于非肝细胞癌组(75±3 vs 60±3 cm²/m²,P=0.001)。
  • 男性内脏脂肪指数≥65 cm²/m²者肝细胞癌风险更高(HR 1.90;95%CI 1.31-2.76;P=0.001)。
  • 男性肝细胞癌患者肝移植后,校正米兰标准,内脏脂肪指数≥65 cm²/m²与复发风险更高独立相关(HR 5.34;95%CI 1.19-23.97;P=0.03)。

核心结论

  • 高内脏脂肪指数是男性肝硬化患者肝细胞癌的独立危险因素,也是肝移植后肝细胞癌复发的独立危险因素。

研究设计与样本

  • 评估接受肝移植评估的肝硬化患者(n=678;457例男性;289例伴肝细胞癌)的身体成分分析。
  • 其中接受肝移植的患者(n=247;168例男性;96例伴肝细胞癌,78例男性)后续接受身体成分分析。
  • 通过第三腰椎水平计算机断层扫描量化内脏脂肪组织、皮下脂肪组织和总脂肪组织,并报告为以身高标准化的横截面积指数(平方厘米每平方米)。

主要发现

  • 肝移植评估时,男性肝细胞癌患者内脏脂肪指数高于非肝细胞癌患者(75±3 vs 60±3 cm²/m²,P=0.001)。
  • 男性肝细胞癌患者皮下脂肪组织指数和总脂肪组织指数均高于非肝细胞癌患者。
  • 多因素分析显示,男性内脏脂肪指数≥65 cm²/m²者肝细胞癌风险更高(HR 1.90;95%CI 1.31-2.76;P=0.001)。
  • 男性肝细胞癌患者肝移植后,校正米兰标准,内脏脂肪指数≥65 cm²/m²与肝细胞癌复发风险更高独立相关(HR 5.34;95%CI 1.19-23.97;P=0.03)。

关键数值与推荐

  • 男性内脏脂肪指数≥65 cm²/m²为肝细胞癌风险增高的阈值(HR 1.90;95%CI 1.31-2.76;P=0.001)。
  • 男性肝细胞癌患者肝移植后,内脏脂肪指数≥65 cm²/m²且校正米兰标准后,复发风险增高(HR 5.34;95%CI 1.19-23.97;P=0.03)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Visceral adipose tissue (VAT) is a metabolically active organ, associated with higher risk of malignancies. We evaluated whether VAT is associated with the risk of hepatocellular carcinoma (HCC) in patients presenting with cirrhosis as well as HCC recurrence after liver transplantation (LT). Patients with cirrhosis (n = 678; 457 male) who were assessed for LT (289 with HCC) were evaluated for body composition analysis. Patients who underwent LT (n = 247, 168 male) were subsequently evaluated for body composition, and 96 of these patients (78 male) had HCC. VAT, subcutaneous adipose tissues, and total adipose tissues were quantified by computed tomography at the level of the third lumbar vertebra and reported as indexes (cross-sectional area normalized for height [square centimeters per square meter]). At the time of LT assessment, the VAT index (VATI) was higher in male patients with HCC compared to non-HCC patients (75 ± 3 versus 60 ± 3 cm2 /m2 , P = 0.001). The VATI, subcutaneous adipose tissue index, and total adipose tissue index were higher in male patients with HCC compared to non-HCC patients. By multivariate analysis, male patients with VATI ≥65 cm2 /m2 had a higher risk of HCC (hazard ratio, 1.90; 95% confidence interval, 1.31-2.76; P = 0.001). In male patients with HCC who underwent LT, a VATI ≥65 cm2 /m2 adjusted for Milan criteria was independently associated with higher risk of HCC recurrence (hazard ratio, 5.34; 95% confidence interval, 1.19-23.97; P = 0.03). CONCLUSION: High VATI is an independent risk factor for HCC in male patients with cirrhosis and for recurrence of HCC after LT. (Hepatology 2018;67:914-923).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Montano-Loza AJ, Mazurak VC, Ebadi M, et al. Visceral adiposity increases risk for hepatocellular carcinoma in male patients with cirrhosis and recurrence after liver transplant. Hepatology. 2018. PMID: 29023899. doi:10.1002/hep.29578

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。